Skip to Content
Morningstar

Takeda Pharmaceutical Co Ltd ADR TAK

Morningstar Rating
Unlock
Stock XNYS Rating as of
$13.77 +0.10 (0.73%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

View History
TAK is trading at a 848% premium.
Price
$13.83
Fair Value
$97.88
Uncertainty
High
1-Star Price
$93.70
5-Star Price
$96.97
Economic Moat
Lmt
Capital Allocation
—
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TAK is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$13.67
Day Range
$13.69–13.79
52-Week Range
$12.58–16.39
Bid/Ask
$13.50 / $13.94
Market Cap
$43.65 Bil
Volume/Avg
2.5 Mil / 1.7 Mil

Key Statistics

Price/Earnings (Normalized)
15.10
Price/Sales
1.47
Dividend Yield (Trailing)
4.44%
Dividend Yield (Forward)
4.24%
Total Yield
4.48%

Company Profile

Takeda Pharmaceutical is Japan’s largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company’s five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Large Core
Total Number of Employees
49,281
Website
https://www.takeda.com

Competitors

Valuation

View More
Metric
TAK
4519
4568
Price/Earnings (Normalized)
 15.1030.1755.42
Price/Book Value
 0.905.886.43
Price/Sales
 1.479.506.78
Price/Cash Flow
 7.2126.2441.44
Price/Earnings
TAK
4519
4568

Financial Strength

Metric
TAK
4519
4568
Quick Ratio
 0.514.022.32
Current Ratio
 1.115.093.01
Interest Coverage
 1.35—35.14
Quick Ratio
TAK
4519
4568

Profitability

Metric
TAK
4519
4568
Return on Assets (Normalized)
 5.19%18.61%6.99%
Return on Equity (Normalized)
 11.01%22.00%12.93%
Return on Invested Capital (Normalized)
 7.28%21.98%10.69%
Return on Assets
TAK
4519
4568
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
WsmxltzmkWss$82.1 Bil
 Merck KGaA ADR
MKKGY
WncgtngwlWsnzt$75.2 Bil
 Haleon PLC ADR
HLN
PpqpghcjcVpx$41.4 Bil
 Viatris Inc
VTRS
YfxfyrycRcth$14.4 Bil
 Dr Reddy's Laboratories Ltd ADR
RDY
ZssvjnpqzVjjm$13.7 Bil
 Catalent Inc
CTLT
JvwprhbnmMqwlsf$10.6 Bil
 Perrigo Co PLC
PRGO
JdqxxrmMynvb$3.8 Bil
 Prestige Consumer Healthcare Inc
PBH
GqzdmtlrQxkbtx$3.5 Bil
 Curaleaf Holdings Inc
CURLF
YmclzrksVlk$3.0 Bil
 Green Thumb Industries Inc
GTBIF
HxxzwkpsnXklx$2.7 Bil

Sponsor Center